Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

Orszagos Koranyi Pulmonologiai Intezet ( Site 1301), Budapest

Orszagos Onkologiai Intezet ( Site 1310), Budapest

Uzsoki Utcai Korhaz ( Site 1303), Budapest

Saint-Luc UCL ( Site 1005), Brussels

Reformatus Pulmonologiai Centrum ( Site 1304), Törökbálint

Calvary Mater Newcastle ( Site 3000), Waratah

Campbelltown Hospital ( Site 3002), Campbelltown

Nepean Hospital ( Site 3001), Kingswood

UZ Leuven ( Site 1002), Leuven

Western Health-Sunshine Hospital ( Site 3004), St Albans

Austin Health-Austin Hospital ( Site 3006), Heidelberg

Frankston Hospital-Oncology and Haematology ( Site 3007), Frankston

Gold Coast University Hospital ( Site 3003), Southport

"MHAT Uni Hospital OOD ( Site 2507)", Panagyurishte

CHU UCL Namur Site de Godinne ( Site 1004), Yvoir

Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1306), Kecskemét

Grand Hopital de Charleroi ( Site 1003), Gilly

C.I.U. Hopital Ambroise Pare ( Site 1001), Mons

Groote Schuur Hospital ( Site 5002), Cape Town

AZ Delta ( Site 1000), Roeselare

Petz Aladar Megyei Oktato Korhaz ( Site 1312), Győr

Memorial Sloan Kettering Cancer Center ( Site 0069), New York

National Cancer Center ( Site 3306), Goyang-si

Memorial Sloan Kettering - Westchester-Thoracic Oncology ( Site 0134), Harrison

Institute for Oncology and Radiology of Serbia ( Site 2995), Belgrade

Memorial Sloan Kettering - Nassau ( Site 0131), Uniondale

Memorial Sloan Kettering- Commack ( Site 0132), Commack

Clinique Clairval ( Site 1108), Marseille

SA Pohja-Eesti Regionaalhaigla ( Site 2201), Tallinn

Seoul National University Bundang Hospital ( Site 3301), Seongnam-si

The Catholic University of Korea St. Vincent s Hospital ( Site 3303), Suwon

Penn State Hershey Cancer Institute ( Site 0081), Hershey

Georgetown University ( Site 0017), Washington D.C.

IRCCS Ospedale San Raffaele ( Site 1500), Milan

Istituto Nazionale dei Tumori ( Site 1504), Milan

Istituto Europeo di Oncologia ( Site 1501), Milan

"Communal Noncommercial Enterprise Podillia Regional Oncolog-Chemotherapy Department ( Site 2114)", Vinnytsia

Institut za plucne bolesti Vojvodine Sremska Kamenica ( Site 2991), Kamenitz

Harry & Jeanette Weinberg Cancer Institute ( Site 0045), Baltimore

Azienda Ospedaliera Spedali Civili di Brescia ( Site 1512), Brescia

Hospital Universitario 12 de Octubre ( Site 1902), Madrid

"Municipal non-profit Enterprise Khmelnytskyi Regional Antitumor Center ( Site 2115)", Khmelnytskyi

Hospital Regional Universitario de Malaga ( Site 1905), Málaga

Saint Francis Cancer Center ( Site 0087), Greenville

Hospital Universitario Central de Asturias ( Site 1900), Oviedo

CHU de Bordeaux Hop St ANDRE ( Site 1115), Bordeaux

Moffitt Cancer Center ( Site 0137), Tampa

Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 2009), Istanbul

Medipol Universite Hastanesi ( Site 2005), Istanbul

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 2003), Istanbul

Ege Universitesi Tip Fakultesi Hastanesi ( Site 2001), Izmir

IRCCS Istituto Oncologico Veneto ( Site 1506), Padua

Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento-Oncology Unit ( Site 1513), Verona

The University of Tennessee Medical Center ( Site 0116), Knoxville

CHU Grenoble -Hop Michallon ( Site 1102), Grenoble

University of Kentucky Chandler Medical Center ( Site 0138), Lexington

Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 1907), Seville

A O U Policlinico di Modena ( Site 1503), Modena

Keimyung University Dongsan Hospital CRC room 1 ( Site 3302), Daegu

Fairview Hospital-Moll Cancer Center ( Site 0141), Cleveland

Cleveland Clinic - Hillcrest Hospital-Hillcrest Hospital Cancer Center ( Site 0140), Mayfield Heights

Cleveland Clinic Main ( Site 0139), Cleveland

Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0401), Guadalajara

Institut De Cancerologie De L Ouest ( Site 1110), Saint-Herblain

Fort Wayne Medical Oncology and Hematology ( Site 0034), Fort Wayne

VA Ann Arbor Healthcare System ( Site 0050), Ann Arbor

Inje University Haeundae Paik Hospital ( Site 3307), Busan

Institut de Cancerologie de l Ouest Site Paul Papin ( Site 1103), Angers

Azienda Ospedaliero Universitaria Careggi ( Site 1509), Florence

LSMUL Kauno Klinikos ( Site 2301), Kaunas

SA Tartu Ulikooli Kliinikum ( Site 2200), Tartu

Anti-Cancer Hospital of Thessaloniki Theagenio ( Site 1204), Thessaloniki

St. Vincent Healthcare Frontier Cancer Center ( Site 0056), Billings

University of Chicago Medical Center ( Site 0136), Chicago

Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 2110), Kharkiv

"Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0404)", Monterrey

Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0061), Omaha

Overton Brooks VAMC ( Site 0041), Shreveport

Hopitaux Universitaires Paris Centre-Hopital Cochin ( Site 1105), Paris

Texas Oncology - Dallas (Presbyterian)_McIntyre ( Site 0098), Dallas

Texas Oncology - Dallas (Sammons) ( Site 0093), Dallas

MD Anderson Cancer Center ( Site 0100), Houston

Millennium Research & Clinical Development ( Site 0143), Houston

H.I.A. Sainte-Anne ( Site 1101), Toulon

Ironwood Cancer & Research Centers ( Site 0007), Chandler

Loma Linda University Cancer Center ( Site 0011), Loma Linda

Hopital Avicenne ( Site 1106), Bobigny

Providence Regional Cancer Partnership ( Site 0106), Everett

Multicare Institute For Research And Innovation ( Site 0108), Tacoma

Virginia Mason Memorial- North Star Lodge Cancer Center ( Site 0112), Yakima

Medical Oncology Associates, PS ( Site 0142), Spokane

Peking Union Medical College Hospital ( Site 3102), Beijing

Cancer Hospital Chinese Academy of Medical Sciences ( Site 3104), Beijing

Beijing Cancer hospital-Oncology Radiotherapy Department ( Site 3140), Beijing

Spitalul Municipal Ploiesti ( Site 2801), Ploieşti

Main Military Clinical Hospital n.a. N.N.Burdenko ( Site 1812), Moscow

MROI n.a. P.A. Herzen - branch of FSBI NMICR of MoH of Russia ( Site 1800), Moscow

Beijing Cancer Hospital ( Site 3127), Beijing

The First Hospital of Jilin University ( Site 3132), Changchun

Moscow Regional Oncological Dispensary-Oncology (thoracic surgery) Department №1 ( Site 1815), Balashikha

Shanghai Chest Hospital ( Site 3107), Shanghai

Shanghai Pulmonary Hospital ( Site 3101), Shanghai

Jiangsu Cancer Hospital ( Site 3139), Nanjing

Affiliated Cancer Hospital of Shandong First Medical University ( Site 3100), Jinan

Tianjin Medical University Cancer Institute & Hospital ( Site 3103), Tianjin

Cabinet Medical Oncomed ( Site 2802), Timișoara

Hangzhou Cancer Hospital ( Site 3129), Hanghzou

The 1st Affil Hosp of College of Medicine, Zhejiang Univ ( Site 3131), Hangzhou

Zhejiang Cancer Hospital ( Site 3108), Hangzhou

The Second Affiliated Hospital of Nanchang University ( Site 3106), Nanchang

Fujian Provincial Cancer Hospital ( Site 3126), Fuzhou

The First Affiliated Hospital of Xiamen University ( Site 3121), Xiamen

Institutul Oncologic Prof.Dr. Ion Chiricuta Cluj-Napoca ( Site 2803), Cluj-Napoca

Chongqing Cancer Hospital ( Site 3135), Chongqing

Daping Hospital,Third Military Medical University ( Site 3136), Chongqing

Amethyst Radiotherapy Center-Oncologie Medicala ( Site 2805), Florești

Xiangya Hospital of Central South University ( Site 3137), Changsha

Second Xiangya Hospital of Central-South University ( Site 3128), Changsha

Hunan Cancer Hospital ( Site 3133), Changsha

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1814), Kazan'

Tongji Medical College Huazhong University of Science and Technology ( Site 3138), Wuhan

Union Hospital, Tongji Medical College of HUST ( Site 3123), Wuhan

Hubei Cancer Hospital ( Site 3120), Wuhan

Henan Cancer Hospital ( Site 3105), Zhengzhou

West China Hospital of Sichuan University ( Site 3114), Chengdu

Peking University Shenzhen Hospital ( Site 3118), Shenzhen

Cancer Hospital Chinese Academy Of Medical Sciences. Shenzhen Center ( Site 3113), Shenzhen

Nizhniy Novgorod Region Oncology Dispensary ( Site 1811), Nizhny Novgorod

Sverdlovsk Regional Oncology Hospital ( Site 1807), Yekaterinburg

Omsk Clinical Oncology Dispensary ( Site 1806), Omsk

Rambam Health Care Campus-Oncology Division ( Site 1401), Haifa

Chaim Sheba Medical Center ( Site 1400), Ramat Gan

Memorial Sloan Kettering - Basking Ridge ( Site 0133), Basking Ridge

John Theurer Cancer Center ( Site 0064), Hackensack

Memorial Sloan Kettering - Monmouth ( Site 0135), Middletown

Memorial Sloan Kettering - Bergen ( Site 0130), Montvale

Rutgers Cancer Institute of New Jersey ( Site 0123), New Brunswick

Cross Cancer Institute ( Site 0206), Edmonton

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0212), Hamilton

CIUSSS Ouest de l Ile - St-Mary s Hospital ( Site 0202), Montreal

McGill University Health Centre ( Site 0210), Montreal

CIUSSS de la Mauricie et du Centre du Quebec ( Site 0200), Trois-Rivières

C.H. de Saint Quentin ( Site 1111), Saint-Quentin

Henry Dunant Hospital ( Site 1205), Athens

Sotiria Regional Chest Diseases Hospital of Athens ( Site 1200), Athens

University General Hospital of Herakleion ( Site 1202), Heraklion

University General Hospital of Larisa ( Site 1201), Larissa

Policlinico Universitario Agostino Gemelli ( Site 1505), Roma

Aichi Cancer Center ( Site 4010), Nagoya

Kobe Minimally Invasive Cancer Center ( Site 4003), Kobe

Takarazuka City Hospital ( Site 4013), Takarazuka

Kanagawa Cancer Center ( Site 4001), Yokohama

Kansai Medical University Hospital ( Site 4009), Hirakata

Osaka Medical and Pharmaceutical University Hospital ( Site 4007), Takatsuki

Shizuoka Cancer Center ( Site 4014), Nakatogari

National Hospital Organization Kyushu Cancer Center ( Site 4000), Fukuoka

Niigata Cancer Center Hospital ( Site 4004), Niigata

Okayama University Hospital ( Site 4012), Okayama

Osaka International Cancer Institute ( Site 4005), Osaka

National Cancer Center Hospital ( Site 4015), Tokyo

Juntendo University Hospital ( Site 4008), Tokyo

Tokyo Metropolitan Komagome Hospital ( Site 4011), Tokyo

Cancer Institute Hospital of JFCR ( Site 4006), Tokyo

Showa Medical University Hospital ( Site 4002), Tokyo

Nacionalinis Vezio Institutas ( Site 2300), Vilnius

Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 1704), Lisbon

Inst. Portugues de Oncologia de Lisboa Francisco Gentil EPE ( Site 1705), Lisbon

Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. ( Site 1701), Porto

S.C.Focus Lab Plus S.R.L ( Site 2804), Bucharest

Steve Biko Academic Hospital ( Site 5000), Pretoria

Asan Medical Center ( Site 3308), Songpagu

Severance Hospital Yonsei University Health System ( Site 3304), Seoul

Samsung Medical Center ( Site 3300), Seoul

Hospital Duran i Reynals ( Site 1903), L'Hospitalet de Llobregat

Hospital Universitari Vall d Hebron ( Site 1904), Barcelona

Ankara Bilkent Sehir Hastanesi ( Site 2007), Ankara

LISOD. Hospital ( Site 2111), Pliuty

Medical Center of Yuriy Spizhenko LLC.-Clinical Trial ( Site 2104), Kapitanivka Village

Clinic of National Cancer Institute ( Site 2101), Kyiv

Medical Center Verum ( Site 2106), Kyiv

Kyiv City Clinical Oncology Center ( Site 2100), Kyiv

Royal Infirmary Aberdeen ( Site 2403), Aberdeen

Ninewells Hospital and Medical School ( Site 2401), Dundee

Taunton and Somerset Hospital ( Site 2404), Taunton

Barts Health NHS Trust ( Site 2409), London

Guy s & St Thomas NHS Foundation Trust ( Site 2408), London

The Christie NHS Foundation Trust ( Site 2405), Manchester